Please Wait.....
Report
China Surgical Site Infection Control Market Forecast 2024-2032
Market Report I 2024-11-07 I 130 Pages I Inkwood Research
KEY FINDINGS
The China surgical site infection control market is projected to record a CAGR of 6.15% during the projection period of 2024-2032. The market was valued at $325.85 million in 2023 and is expected to reach $559.05 million by 2032. The growth of the surgical site infection (SSI) control market in China is primarily driven by the high prevalence of SSIs, increasing awareness about infection control, and the emphasis on enhancing healthcare efficiency and patient safety. With a growing number of surgical procedures and a rising focus on preventing hospital-acquired infections, the market is expanding as healthcare providers adopt comprehensive infection control strategies to mitigate risks and improve patient outcomes.
MARKET INSIGHTS
Surgical site infections are a common type of hospital-acquired infection (HAI) that occur after surgical procedures, specifically affecting the area around the surgical incision. In China, the prevalence of SSIs is notably high, and several studies have aimed to quantify infection rates. One comprehensive study reported an overall SSI incidence of approximately 4.7% across various surgical departments, including internal medicine, oncology, hematology, neurology, and obstetrics. In this study, SSIs accounted for about 42% of all nosocomial infections.
Other independent studies highlighted particularly high incidence rates in specific procedures such as laryngectomy (21.1%), general surgery (18.8%), thoracic surgery (13.9%), and bone surgery (11.2%). Conversely, lower rates were observed in pancreatic surgery (7.1%), neurosurgery (3.0%), and Caesarean sections (0.7%). In these cases, the most common pathogens identified were Staphylococcus aureus and Pseudomonas aeruginosa.
The high prevalence of SSIs presents a significant burden on the healthcare system, as these infections lead to prolonged hospital stays and additional treatments. This not only affects patient recovery and satisfaction but also results in increased healthcare costs. As a result, there is a growing emphasis on implementing strategies and interventions aimed at reducing SSI rates.
These efforts, which include enhanced infection surveillance, adherence to surgical protocols, and improved sterilization techniques, have the potential to deliver substantial cost savings and boost overall healthcare efficiency. Such factors are expected to drive the growth of the SSI control market in China over the forecast period as hospitals and healthcare providers invest more in preventive measures to ensure patient safety and reduce the incidence of these infections.
SEGMENTATION ANALYSIS
The China surgical site infection control market segmentation includes procedure, type of infection, end-user, and product. The end-user segment is further classified into hospitals and ambulatory surgical centers. Ambulatory care refers to medical services provided in facilities where patients are not required to stay overnight. These facilities include hospital-based outpatient clinics, non-hospital-based clinics, physician offices, urgent care centers, ambulatory surgical centers (ASCs), public health clinics, imaging centers, oncology clinics, ambulatory behavioral health and substance abuse clinics, as well as physical therapy and rehabilitation centers.
Despite the convenience of ambulatory surgeries, healthcare-associated infections remain a common complication. However, most surgical-site infections are preventable due to stringent regulations that ensure ASCs adhere to safety standards comparable to those of hospitals.
This controlled environment, combined with advancements in technology, anesthesia, and minimally invasive surgical techniques, has significantly improved the safety of surgeries performed in ASCs. ASCs are also required to operate independently and cannot share physical space, even on a temporary basis, with hospital outpatient surgery departments or Medicare-participating independent diagnostic testing facilities (IDTFs).
COMPETITIVE INSIGHTS
Some of the top enterprises operating in the China surgical site infection control market include 3M Company, Ansell Ltd, Becton, Dickinson and Company (BD), etc.
Becton, Dickinson, and Company (BD) is a global leader in medical technology, specializing in the development, manufacturing, and distribution of medical devices, laboratory equipment, and diagnostic products. The company's product portfolio includes syringes and pen needles, intravenous catheters, infusion pumps and disposables, automated medication dispensing systems, respiratory ventilation and diagnostic equipment, as well as diagnostic specimens.
BD also offers instruments designed to detect a wide range of infectious diseases, healthcare-associated infections, cancers, and clinical research tools. Its products serve life science researchers, healthcare institutions, clinical laboratories, the pharmaceutical industry, and the general public. With a broad geographic presence, BD operates across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. The company is headquartered in New Jersey, USA.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
2.6.1. HIGH EMPHASIS ON ENVIRONMENTAL HYGIENE BOOSTS THE SSI CONTROL MARKET
2.6.2. DISPOSABLE AND SINGLE-USE PRODUCTS ARE SHAPING THE SURGICAL INFECTION CONTROL LANDSCAPE
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGE IN GERIATRIC POPULATION
3.1.2. INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
3.1.3. IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL-ACQUIRED INFECTIONS
3.2. KEY RESTRAINTS
3.2.1. LACK OF AWARENESS ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS
3.2.2. SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS
3.2.3. RISING USE OF OUTPATIENT TREATMENTS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. RISING RATE OF SURGICAL PROCEDURES
4.1.2. EXPANSION OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
4.1.3. ADVANCEMENTS IN TECHNOLOGY FOR PREVENTING SURGICAL SITE INFECTIONS
4.2. PESTLE ANALYSIS
4.2.1. POLITICAL
4.2.2. ECONOMICAL
4.2.3. SOCIAL
4.2.4. TECHNOLOGICAL
4.2.5. LEGAL
4.2.6. ENVIRONMENTAL
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTIONS
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. MARKET CONCENTRATION ANALYSIS
5. MARKET BY PROCEDURE
5.1. LAPAROSCOPY
5.2. ORTHOPEDIC SURGERY
5.3. CARDIOVASCULAR
5.4. OBSTETRICS AND GYNECOLOGY
5.5. WOUND CLOSURE
5.6. PLASTIC & RECONSTRUCTIVE SURGERY
5.7. THORACIC SURGERY
5.8. MICROVASCULAR
5.9. UROLOGY
5.10. NEUROSURGERY
5.11. OTHER PROCEDURES
6. MARKET BY TYPE OF INFECTION
6.1. SUPERFICIAL INCISIONAL SSI
6.2. DEEP INCISIONAL SSI
6.3. ORGAN OR SPACE SSI
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
8. MARKET BY PRODUCT
8.1. DISINFECTANTS
8.1.1. SKIN DISINFECTANTS
8.1.2. HAND DISINFECTANTS
8.2. MANUAL REPROCESSORS SOLUTIONS
8.3. SURGICAL DRAPES
8.4. SURGICAL GLOVES
8.5. SKIN PREPARATION SOLUTIONS
8.6. SURGICAL IRRIGATION
8.7. SURGICAL SCRUBS
8.8. HAIR CLIPPERS
8.9. MEDICAL NONWOVENS
8.10. OTHER PRODUCTS
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PARTNERSHIPS & AGREEMENTS
9.1.3. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. 3M COMPANY
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCTS
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. ANSELL LTD
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. BECTON, DICKINSON AND COMPANY
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCTS
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. JOHNSON & JOHNSON
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. KIMBERLY-CLARK
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCTS
9.2.5.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - SURGICAL SITE INFECTION CONTROL
TABLE 2: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: LIST OF MERGERS & ACQUISITIONS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: MARKET CONCENTRATION ANALYSIS
FIGURE 4: CHINA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2023
FIGURE 5: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 6: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 7: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 8: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 9: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 10: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 11: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 12: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 13: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 15: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 16: CHINA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY TYPE OF INFECTION, IN 2023
FIGURE 17: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 19: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 20: CHINA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 21: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 22: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 23: CHINA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 24: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 25: CHINA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY DISINFECTANTS, IN 2023
FIGURE 26: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 27: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 28: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2024-2032 (IN $ MILLION)
FIGURE 29: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 30: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 31: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 32: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 33: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 34: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 35: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 36: CHINA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security